TYMS and colorectal carcinoma: Patients diagnosed with CRC who were given chemotherapy based on 5-FU to address their condition, have been shown to have higher TYMS expression and lower survival when the insertion (ins) allele or the triple tandem repeat (3R variant) is present (29).